Amgen (AMGN) free cash flow was $8.1B in FY2025 (-22% YoY). The tables below show the complete quarterly and annual free cash flow history, sourced from SEC EDGAR 10-K and 10-Q filings.
Annual Free Cash Flow
Fiscal Year
Free Cash Flow
YoY
2025
$8.1B
-22%
2024
$10.4B
+41%
2023
$7.4B
-16%
2022
$8.8B
+5%
2021
$8.4B
-15%
2020
$9.9B
+16%
2019
$8.5B
-19%
2018
$10.6B
+0%
2017
$10.5B
+10%
2016
$9.5B
+5%
2015
$9.1B
+14%
2014
$7.9B
+42%
2013
$5.6B
+8%
2012
$5.2B
+14%
2011
$4.6B
-13%
2010
$5.2B
-10%
2009
$5.8B
+9%
2008
$5.3B
+29%
2007
$4.1B
Recent Quarterly Free Cash Flow
Quarter
Free Cash Flow
Q1 2026
$1.5B
Q4 2025
$961M
Q3 2025
$4.2B
Q2 2025
$1.9B
Q1 2025
$980M
Q4 2024
$4.4B
Q3 2024
$3.3B
Q2 2024
$2.2B
Q1 2024
$459M
Q4 2023
$289M
Q3 2023
$2.5B
Q2 2023
$3.8B
Source: AMGN on EDGAR. Data from SEC EDGAR 10-K and 10-Q filings. Updated quarterly.